Cabozantinib (Compound)

Synonyms:Cabozantinib, 849217-68-1, XL184, Cometriq, XL-184, XL 184, BMS-907351, XL-184 free base, BMS 907351, Cabozantinib (XL184, BMS-907351)

Pubchem:PUBCHEM:25102847

Id:d8633630-0df6-5886-b8f5-20b2c2883700

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Cabozantinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Cabozantinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Cabozantinib.

Results found

Linked to

	Label	Description
	BRD-K51544265-001-01-8 Substance (Entity type)	A Substance
	N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide in similarity relationship with Cabozantinib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cabozantinib negatively regulates PLAUR Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cabozantinib bioactivity Mast/stem cell growth factor receptor Kit Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cabozantinib indication Metastatic Renal Cell Carcinoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cabozantinib bioactivity Receptor-type tyrosine-protein kinase FLT3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cabozantinib bioactivity Breakpoint cluster region protein Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Methyl-naphthalen-1-ylmethyl-((E)-3-phenyl-allyl)-amine in similarity relationship with Cabozantinib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cabozantinib bioactivity Fibroblast growth factor receptor 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cabozantinib positively regulates HNMT Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K51544265-001-01-8

Substance (Entity type)

A Substance

N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-(4-(trifluoromethyl)phenyl)-1,4,5,6-tetrahydropyridine-3-carboxamide in similarity relationship with Cabozantinib

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Cabozantinib negatively regulates PLAUR

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Cabozantinib bioactivity Mast/stem cell growth factor receptor Kit

Knowledge Graph Assertion (Entity type)